PHARMADAX INC. – Trademark Portfolio

Entity Type: 03

PHARMADAX INC. holds 3 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 42 (Computer & Scientific) — 2 filings in this category. The portfolio also extends into Class 5 (Pharmaceuticals) across 2 Nice Classification classes. Currently, 3 trademarks are registered. Notable registered marks include PHD and PHARMADAX. The owner is based in NEW TAIPEI CITY.

5F-L, NO.236, LIANCHENG RD.

ZHONGHE DISTRICT

NEW TAIPEI CITY 23553 , TW

3 Total Trademarks

Add to watchlist:

No watchlists yet
Loading...
By Date
By Name
Filter by Class:

PHARMADAX
PHARMADAX
Registered 2018
PHARMADAX
PHARMADAX
Registered 2018
PHD
PHD
Registered 2018

Trademark Classifications

PHARMADAX INC.'s trademark portfolio spans 2 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.

42
Computer & Scientific (2 filings)

Scientific and technological services; industrial analysis and research services

5
Pharmaceuticals (1 filing)

Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes

Frequently Asked Questions

How many trademarks does PHARMADAX INC. have?

PHARMADAX INC. has 3 U.S. trademarks filed with the USPTO. Of these, 3 registered.

What trademark classes does PHARMADAX INC. file in?

PHARMADAX INC. files trademarks across 2 Nice Classification classes. The most active classes are Class 42 (Computer & Scientific), Class 5 (Pharmaceuticals). Class 42 covers scientific and technological services; industrial analysis and research services.

What are PHARMADAX INC.'s most well-known trademarks?

PHARMADAX INC.'s registered trademark portfolio includes well-known marks such as PHD and PHARMADAX. These are among 3 currently registered trademarks in the portfolio.

What is PHARMADAX INC.'s trademark registration success rate?

PHARMADAX INC. has a 100% trademark registration rate, with 3 out of 3 resolved applications resulting in successful registration. Currently, 0 applications are pending review.